Nutex Health (NASDAQ:NUTX) Reaches New 1-Year High – Here’s Why
by Mitch Edgeman · The Markets DailyShares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) reached a new 52-week high on Monday. The stock traded as high as $225.25 and last traded at $225.14, with a volume of 126373 shares traded. The stock had previously closed at $216.50.
Analyst Ratings Changes
A number of brokerages recently weighed in on NUTX. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Lake Street Capital restated a “buy” rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Zacks Research raised shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $317.50.
Check Out Our Latest Analysis on NUTX
Nutex Health Trading Up 3.9%
The company has a market capitalization of $1.54 billion, a PE ratio of 8.83 and a beta of 0.55. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The stock has a fifty day moving average of $188.64 and a two-hundred day moving average of $151.91.
Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The business had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. As a group, sell-side analysts anticipate that Nutex Health Inc. will post 27.58 earnings per share for the current fiscal year.
Insider Buying and Selling at Nutex Health
In other news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the sale, the director directly owned 400 shares in the company, valued at approximately $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 44.68% of the company’s stock.
Institutional Trading of Nutex Health
Several hedge funds have recently added to or reduced their stakes in NUTX. BlackRock Inc. purchased a new stake in Nutex Health during the second quarter valued at about $69,612,000. Winmill & CO. Inc. purchased a new position in shares of Nutex Health in the second quarter worth about $11,168,000. Empowered Funds LLC purchased a new position in shares of Nutex Health in the second quarter worth about $7,720,000. SG Americas Securities LLC lifted its stake in shares of Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after acquiring an additional 29,449 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in Nutex Health during the 2nd quarter valued at about $3,956,000. 5.32% of the stock is owned by institutional investors.
Nutex Health Company Profile
Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.
The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.
See Also
- Five stocks we like better than Nutex Health
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks